For patients with heart failure with preserved ejection fraction (HFpEF), endovascular treatment (EVT) improves left ...
For patients with heart failure with preserved ejection fraction (HFpEF), endovascular treatment (EVT) improves left ...
For patients with HFPEF and other underlying comorbidities, such as diabetes or coronary artery disease, treatment with an ACE inhibitor is nonetheless beneficial. The theoretical benefits of ACE ...
Pharmaceutical Technology on MSN2d
EMA CHMP recommends label update to Novo Nordisk’s WegovyThe European Medicines Agency's Committee for Medicinal Products for Human Use has recommended an update to Novo Nordisk’s ...
Bagsværd, Denmark Saturday, September 21, 2024, 15:00 Hrs [IST] ...
Tectonic Therapeutics Inc. (TECX) announced favorable Phase 1a topline data for its lead asset, TX45, a long-acting, potentially ...
TX45 was well-tolerated with no observed immunogenicity, and demonstrated a favorable PK/PD relationship which was used to identify doses for the ...
In addition to improving heart failure symptoms, finerenone reduced the onset of new type 2 diabetes in patients with mildly ...
Zacks.com on MSN1d
NVO Gets Positive CHMP Opinion for Wegovy's Label Update in EUNovo Nordisk A/S NVO announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (“CHMP”) ...
The European Medicines Agency’s (EMA) advisory committee the CHMP has adopted a positive opinion for a label update of Danish ...
Cytokinetics presented positive Phase 1 trial data for CK-586, a potential heart failure treatment, showing safety, ...
I WAS treated by the oncology department in Hereford for my prostate cancer and the staff there were a pleasure to be treated ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback